(BMRN) Biomarin Pharmaceutical complete technical analysis [charts+indicators] | Buy/Sell Biomarin Pharmaceutical | (BMRN) share price targets
Complete technical analysis of Biomarin Pharmaceutical (BMRN) by charts plus indicators, forecast predictions and share price targets for Biomarin Pharmaceutical (BMRN)
Biomarin Pharmaceutical trades in USA in Health Care sector.
Showing technical analysis as on 2024-07-30 View latest technical analysis
10 day averaged volume of Biomarin Pharmaceutical is 1332466
Date | Daily Closing Price | Open | High | Low | Volume |
30 Tue Jul 2024 | 84.39 | 84.20 | 84.91 | 83.62 | 0.767 times |
29 Mon Jul 2024 | 84.07 | 84.34 | 84.96 | 83.21 | 0.818 times |
26 Fri Jul 2024 | 84.59 | 85.66 | 86.45 | 84.07 | 0.798 times |
25 Thu Jul 2024 | 85.59 | 84.64 | 86.80 | 84.60 | 1.524 times |
24 Wed Jul 2024 | 84.63 | 84.42 | 85.01 | 83.82 | 0.581 times |
23 Tue Jul 2024 | 84.43 | 85.28 | 85.85 | 84.37 | 1.132 times |
22 Mon Jul 2024 | 85.31 | 84.34 | 85.78 | 84.04 | 1.136 times |
19 Fri Jul 2024 | 84.09 | 83.16 | 84.20 | 83.11 | 1.414 times |
18 Thu Jul 2024 | 83.34 | 84.83 | 86.24 | 83.32 | 0.97 times |
17 Wed Jul 2024 | 84.66 | 85.49 | 85.94 | 84.20 | 0.803 times |
My analysis of stock is bullish for shortterm, and stock might move up till 85.2 or till 86.9. Use a stoploss of 83.79 and if this stock hits its stoploss, then it can fall down till 82.36
Share price targets for Biomarin Pharmaceutical (BMRN)
Target Type | Value |
Downside Target | 73.68 |
Downside Target | 75.40 |
Downside Target | 80.52 |
Upside Target | 85.04 |
Upside Target | 85.75 |
Upside Target | 86.13 |
Upside Target | 86.24 |
Upside Target | 86.80 |
Upside Target | 88.74 |
Upside Target | 93.36 |
Intraday share price targets for Biomarin Pharmaceutical (BMRN)
Target Type | Value |
Downside Intraday Target | 83.41 |
Downside Intraday Target | 82.44 |
Upside Intraday Target | 85.16 |
Upside Intraday Target | 85.94 |
Downside Intraday Target | 84.19 |
Weekly technical analysis of Biomarin Pharmaceutical (BMRN)
Date | Weekly Closing Price | Open | High | Low | Volume |
30 Tue Jul 2024 | 84.39 | 84.34 | 84.96 | 83.21 | 0.307 times |
26 Fri Jul 2024 | 84.59 | 84.34 | 86.80 | 83.82 | 1.072 times |
19 Fri Jul 2024 | 84.09 | 85.19 | 86.24 | 83.11 | 0.996 times |
12 Fri Jul 2024 | 85.02 | 81.71 | 85.75 | 81.37 | 4.366 times |
05 Fri Jul 2024 | 81.45 | 82.82 | 82.82 | 80.53 | 0.469 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Biomarin Pharmaceutical (BMRN)
Date | Monthly Closing Price | Open | High | Low | Volume |
30 Tue Jul 2024 | 84.39 | 82.83 | 86.80 | 80.53 | 0.313 times |
28 Fri Jun 2024 | 82.33 | 75.75 | 86.13 | 75.40 | 2.011 times |
31 Fri May 2024 | 75.07 | 81.07 | 85.04 | 73.68 | 1.046 times |
30 Tue Apr 2024 | 80.76 | 86.98 | 93.36 | 80.52 | 1.65 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Biomarin Pharmaceutical (BMRN)
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Biomarin Pharmaceutical stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Biomarin Pharmaceutical in short term but the sell signal is initial and weak.
Biomarin Pharmaceutical Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Biomarin Pharmaceutical in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Biomarin Pharmaceutical is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 84.56 and Biomarin Pharmaceutical (BMRN) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Biomarin Pharmaceutical (BMRN) stock. Volume based technical analysis of Biomarin Pharmaceutical (BMRN) stock is negative.
Biomarin Pharmaceutical Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Biomarin Pharmaceutical stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Biomarin Pharmaceutical in short term but the sell signal is initial and weak.
Biomarin Pharmaceutical Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Biomarin Pharmaceutical in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Biomarin Pharmaceutical is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 84.56 and Biomarin Pharmaceutical (BMRN) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Biomarin Pharmaceutical (BMRN) stock. Volume based technical analysis of Biomarin Pharmaceutical (BMRN) stock is negative.
Biomarin Pharmaceutical Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.